Yahoo
    NasdaqCM - Nasdaq Real Time Price USD

    Regencell Bioscience Holdings Limited (RGC)

    6.99 -0.28 (-3.87%)
    As of 11:30:08 AM EDT. Market Open.
    Trade RGC on Coinbase
    Chart Range Bar
    Advanced Chart
    AlphaSpace Chart
    Loading chart for RGC

    What's happening with RGC?

    17m ago     Powered by Yahoo Scout

    RGC coverage centers on Regencell Bioscience’s widening annual loss, no meaningful product revenue, DOJ investigation, and internal-control concerns. The company’s valuation remains highly dependent on future clinical progress and commercialization, while the latest Yahoo Finance data shows the shares down 5.08% in the current regular session on October 29, 2026. Some older articles concern Relevant Gold, another company using the RGC ticker, so those developments should not be attributed to Regencell.

    Powered by Yahoo Scout
    • Previous Close 7.27
    • Open 7.15
    • Bid 5.12 x 200
    • Ask 8.76 x 200
    • Day's Range 6.72 - 7.24
    • 52 Week Range 4.51 - 69.00
    • Volume 66,821
    • Avg. Volume 249,837
    • Market Cap (intraday) 3.466B
    • Beta (5Y Monthly) 1.17
    • PE Ratio (TTM) --
    • EPS (TTM) -0.02
    • Earnings Date (est.) Oct 28, 2026
    • Forward Dividend & Yield -- (0.00%)
    • Ex-Dividend Date --
    • 1y Target Est --

    Regencell Bioscience Holdings Limited focuses on the research, development, and commercialization of Traditional Chinese Medicine (TCM) in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, TCM brain theory, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

    www.regencellbioscience.com

    10

    Full Time Employees

    June 30

    Fiscal Year Ends

    Healthcare

    Sector

    Drug Manufacturers - Specialty & Generic

    Industry

    More about Regencell Bioscience Holdings Limited

    Recent News

    View More
    View More

    Performance Overview

    Trailing total returns as of 10/29/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

    YTD Return

    RGC
    66.71%
    S&P 500 (^GSPC)
    12.90%

    1-Year Return

    RGC
    57.92%
    S&P 500 (^GSPC)
    12.16%

    3-Year Return

    RGC
    1,529.57%
    S&P 500 (^GSPC)
    87.70%

    5-Year Return

    RGC
    1,877.81%
    S&P 500 (^GSPC)
    67.81%

    Statistics

    View More

    Valuation Measures

    Annual

    • Market Cap

    • Enterprise Value

    • Trailing P/E

    • Forward P/E

    • PEG Ratio (current)

    • Price/Sales (ttm)

    • Price/Book (mrq)

    • Enterprise Value/Revenue

    • Enterprise Value/EBITDA

    Financial Highlights

    Profitability and Income Statement

    • Profit Margin

      0.00%

    • Return on Assets (ttm)

      -71.54%

    • Return on Equity (ttm)

      -128.52%

    • Revenue (ttm)

      --

    • Net Income Avi to Common (ttm)

      -11.7M

    • Diluted EPS (ttm)

      -0.02

    Balance Sheet and Cash Flow

    • Total Cash (mrq)

      14.19M

    • Total Debt/Equity (mrq)

      2.22%

    • Levered Free Cash Flow (ttm)

      -2.99M

    View More

    Company Insights

    Research Reports

    View More
    View More

    People Also Watch

    MLGO MicroAlgo Inc.
    2.6901 -1.48%
    SBET Sharplink, Inc.
    7.30 -0.88%
    SMX SMX (Security Matters) Public Limited Company
    1.8100 +1.69%
    NEGG Newegg Commerce, Inc.
    9.97 -3.39%
    PONY Pony AI Inc.
    4.9250 -2.48%
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: